Neurotensin vs Relaxin-3 — mechanism, half-life, dosing, and research status compared. Which is right for your protocol?
Neurotensin (NT) is a 13-amino acid neuropeptide widely distributed throughout the central and peripheral nervous systems, with high concentrations in the hypothalamus, nucleus accumbens, and gastrointestinal tract. Discovered in 1973, neurotensin modulates dopaminergic signaling...
Calculate Neurotensin dose →Relaxin-3 (also called INSL7) is the most ancient member of the insulin/relaxin superfamily and is expressed predominantly in the nucleus incertus (NI) of the brainstem, a structure implicated in stress, arousal, and hippocampal theta rhythm generation. Unlike relaxin-1 and relax...
Calculate Relaxin-3 dose →| Parameter | Neurotensin | Relaxin-3 |
|---|---|---|
| Category | Neuropeptide | Neuropeptide |
| Research | Research | Preclinical Research |
| Half-Life | < 5 min (plasma) | ~30-60 minutes (estimated) |
| Typical Dose | 1-10 nmol/kg (animal) | 100-500 pmol ICV; 1-3 nmol/kg SC |
| Frequency | Variable | Single or twice daily (preclinical) |
| Route | Subcutaneous, Intracerebroventricular | ICV, SC (preclinical) |
| FDA Status | Not approved | Research compound |
Use ASCEND's free reconstitution calculator to get exact syringe draw amounts for your vial.
For research use only. Not medical advice. ASCEND does not conduct or endorse any specific research protocol. Always consult relevant scientific literature and regulatory guidelines.